These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 11704758)

  • 61. A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy related to EIF21B5 mutation.
    Fogli A; Dionisi-Vici C; Deodato F; Bartuli A; Boespflug-Tanguy O; Bertini E
    Neurology; 2002 Dec; 59(12):1966-8. PubMed ID: 12499492
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Analysis of the subunit organization of the eIF2B complex reveals new insights into its structure and regulation.
    Wortham NC; Martinez M; Gordiyenko Y; Robinson CV; Proud CG
    FASEB J; 2014 May; 28(5):2225-37. PubMed ID: 24532666
    [TBL] [Abstract][Full Text] [Related]  

  • 63. EIF2B2 gene mutation causing early onset vanishing white matter disease: a case report.
    Filareto I; Cinelli G; Scalabrini I; Caramaschi E; Bergonzini P; Spezia E; Todeschini A; Iughetti L
    Ital J Pediatr; 2022 Jul; 48(1):128. PubMed ID: 35897042
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficient detection of frequent eIF2B mutations for the rapid molecular diagnosis of CACH/VWM syndrome.
    Ferreira MC; Dorboz I; Boespflug-Tanguy O
    Clin Biochem; 2015 Dec; 48(18):1317-23. PubMed ID: 26162493
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genetic and clinical heterogeneity in eIF2B-related disorder.
    Maletkovic J; Schiffmann R; Gorospe JR; Gordon ES; Mintz M; Hoffman EP; Alper G; Lynch DR; Singhal BS; Harding C; Amartino H; Brown CM; Chan A; Renaud D; Geraghty M; Jensen L; Senbil N; Kadom N; Nazarian J; Yuanjian Feng ; Zuyi Wang ; Hartka T; Morizono H; Vanderver A
    J Child Neurol; 2008 Feb; 23(2):205-15. PubMed ID: 18263758
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Human-induced pluripotent stem cell-derived cerebral organoid of leukoencephalopathy with vanishing white matter.
    Deng J; Zhang J; Gao K; Zhou L; Jiang Y; Wang J; Wu Y
    CNS Neurosci Ther; 2023 Apr; 29(4):1049-1066. PubMed ID: 36650674
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation.
    Federico A; Scali O; Stromillo ML; Di Perri C; Bianchi S; Sicurelli F; De Stefano N; Malandrini A; Dotti MT
    Neurology; 2006 Jul; 67(2):353-5. PubMed ID: 16864840
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Leukoencephalopathy with vanishing white matter: A case report].
    San Antonio-Arce V; Martín Fernández-Mayoralas D; Muñoz-Jareño N; Fresneda-Machado C; Sáiz-Ayala A; Campos-Castelló J
    Rev Neurol; 2006 Nov 1-15; 43(9):535-40. PubMed ID: 17072809
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Proteomics-level analysis of myelin formation and regeneration in a mouse model for Vanishing White Matter disease.
    Gat-Viks I; Geiger T; Barbi M; Raini G; Elroy-Stein O
    J Neurochem; 2015 Aug; 134(3):513-26. PubMed ID: 25920008
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of genotype on the natural history of eIF2B-related leukodystrophies.
    Fogli A; Schiffmann R; Bertini E; Ughetto S; Combes P; Eymard-Pierre E; Kaneski CR; Pineda M; Troncoso M; Uziel G; Surtees R; Pugin D; Chaunu MP; Rodriguez D; Boespflug-Tanguy O
    Neurology; 2004 May; 62(9):1509-17. PubMed ID: 15136673
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Severity of vanishing white matter disease does not correlate with deficits in eIF2B activity or the integrity of eIF2B complexes.
    Liu R; van der Lei HD; Wang X; Wortham NC; Tang H; van Berkel CG; Mufunde TA; Huang W; van der Knaap MS; Scheper GC; Proud CG
    Hum Mutat; 2011 Sep; 32(9):1036-45. PubMed ID: 21560189
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The unfolded protein response in vanishing white matter disease.
    van der Voorn JP; van Kollenburg B; Bertrand G; Van Haren K; Scheper GC; Powers JM; van der Knaap MS
    J Neuropathol Exp Neurol; 2005 Sep; 64(9):770-5. PubMed ID: 16141786
    [TBL] [Abstract][Full Text] [Related]  

  • 73. eIF2B, a mediator of general and gene-specific translational control.
    Pavitt GD
    Biochem Soc Trans; 2005 Dec; 33(Pt 6):1487-92. PubMed ID: 16246152
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Three-dimensional Structure of eIF2B: A Clue to Understanding the Pathogenesis of CACH/VWM Disease].
    Kashiwagi K; Ito T; Yokoyama S
    Brain Nerve; 2017 Jan; 69(1):45-50. PubMed ID: 28126977
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Translational regulation via 5' mRNA leader sequences revealed by mutational analysis of the Arabidopsis translation initiation factor subunit eIF3h.
    Kim TH; Kim BH; Yahalom A; Chamovitz DA; von Arnim AG
    Plant Cell; 2004 Dec; 16(12):3341-56. PubMed ID: 15548739
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Analysis of eIF2B bodies and their relationships with stress granules and P-bodies.
    Moon SL; Parker R
    Sci Rep; 2018 Aug; 8(1):12264. PubMed ID: 30115954
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Vanishing white matter disease in a child presenting with ataxia.
    Wilson CJ; Pronk JC; Van der Knaap MS
    J Paediatr Child Health; 2005; 41(1-2):65-7. PubMed ID: 15670229
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Vanishing white matter disease presenting as opsoclonus myoclonus syndrome in childhood--a case report and review of the literature.
    Klingelhoefer L; Misbahuddin A; Jawad T; Mellers J; Jarosz J; Weeks R; Ray Chaudhuri K
    Pediatr Neurol; 2014 Jul; 51(1):157-64. PubMed ID: 24938145
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Study of translational control of eukaryotic gene expression using yeast.
    Hinnebusch AG; Asano K; Olsen DS; Phan L; Nielsen KH; Valásek L
    Ann N Y Acad Sci; 2004 Dec; 1038():60-74. PubMed ID: 15838098
    [TBL] [Abstract][Full Text] [Related]  

  • 80. No evidence for a role of Ile587Val polymorphism of EIF2B5 gene in multiple sclerosis in Kashmir Valley of India.
    Zahoor I; Asimi R; Haq E
    J Neurol Sci; 2015 Dec; 359(1-2):172-6. PubMed ID: 26671108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.